Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI

Aims: To evaluate the utility of fasudil in a rat model of contrast-associated acute kidney injury (CA-AKI) and explore its underlying mechanism through multiparametric renal magnetic resonance imaging (mpMRI).Methods: Experimental rats (n = 72) were grouped as follows: controls (n = 24), CA-AKI (n...

Full description

Bibliographic Details
Main Authors: Bin Wang, Yongfang Wang, Yan Tan, Jinxia Guo, Haoyuan Chen, Pu-Yeh Wu, Xiaochun Wang, Hui Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.905547/full
_version_ 1818203833740820480
author Bin Wang
Bin Wang
Yongfang Wang
Yan Tan
Jinxia Guo
Haoyuan Chen
Pu-Yeh Wu
Xiaochun Wang
Hui Zhang
author_facet Bin Wang
Bin Wang
Yongfang Wang
Yan Tan
Jinxia Guo
Haoyuan Chen
Pu-Yeh Wu
Xiaochun Wang
Hui Zhang
author_sort Bin Wang
collection DOAJ
description Aims: To evaluate the utility of fasudil in a rat model of contrast-associated acute kidney injury (CA-AKI) and explore its underlying mechanism through multiparametric renal magnetic resonance imaging (mpMRI).Methods: Experimental rats (n = 72) were grouped as follows: controls (n = 24), CA-AKI (n = 24), or CA-AKI + Fasudil (n = 24). All animals underwent two mpMRI studies (arterial spin labeling, T1 and T2 mapping) at baseline and post iopromide/fasudil injection (Days 1, 3, 7, and 13 respectively). Relative change in renal blood flow (ΔRBF), T1 (ΔT1) and T2 (ΔT2) values were assessed at specified time points. Serum levels of cystatin C (CysC) and interleukin-1β (IL-1β), and urinary neutrophil gelatinase-associated lipocalin (NGAL) concentrations were tested as laboratory biomarkers, in addition to examining renal histology and expression levels of various proteins (Rho-kinase [ROCK], α-smooth muscle actin [α-SMA]), hypoxia-inducible factor-1α (HIF-1α), and transforming growth factor-β1 (TGF-β1) that regulate renal fibrosis and hypoxia.Results: Compared with the control group, serum levels of CysC and IL-1β, and urinary NGAL concentrations were clearly increased from Day 1 to Day 13 in the CA-AKI group (all p < 0.05). There were significant reductions in ΔT2 values on Days 1 and 3, and ΔT1 reductions were significantly more pronounced at all time points (Days 1–13) in the CA-AKI + Fasudil group (vs. CA-AKI) (all p < 0.05). Fasudil treatment lowered expression levels of ROCK-1, and p-MYPT1/MYPT1 proteins induced by iopromide, decreasing TGF-β1 expression and suppressing both extracellular matrix accumulation and α-SMA expression relative to untreated status (all p < 0.05). Fasudil also enhanced PHD2 transcription and inhibition of HIF-1α expression after CA-AKI.Conclusions: In the context of CA-AKI, fasudil appears to reduce renal hypoxia, fibrosis, and dysfunction by activating (Rho/ROCK) or inhibiting (TGF-β1, HIF-1α) certain signaling pathways and reducing α-SMA expression. Multiparametric MRI may be a viable noninvasive tool for monitoring CA-AKI pathophysiology during fasudil therapy.
first_indexed 2024-12-12T03:31:38Z
format Article
id doaj.art-a6cef6d01624485f9cde44020e0fd124
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-12T03:31:38Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-a6cef6d01624485f9cde44020e0fd1242022-12-22T00:39:54ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-06-011310.3389/fphar.2022.905547905547Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRIBin Wang0Bin Wang1Yongfang Wang2Yan Tan3Jinxia Guo4Haoyuan Chen5Pu-Yeh Wu6Xiaochun Wang7Hui Zhang8Department of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Medical Imaging, Shanxi Medical University, Taiyuan, ChinaDepartment of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, ChinaGE Healthcare MR Research China, Beijing, ChinaDepartment of Medical Imaging, Shanxi Medical University, Taiyuan, ChinaGE Healthcare MR Research China, Beijing, ChinaDepartment of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, ChinaAims: To evaluate the utility of fasudil in a rat model of contrast-associated acute kidney injury (CA-AKI) and explore its underlying mechanism through multiparametric renal magnetic resonance imaging (mpMRI).Methods: Experimental rats (n = 72) were grouped as follows: controls (n = 24), CA-AKI (n = 24), or CA-AKI + Fasudil (n = 24). All animals underwent two mpMRI studies (arterial spin labeling, T1 and T2 mapping) at baseline and post iopromide/fasudil injection (Days 1, 3, 7, and 13 respectively). Relative change in renal blood flow (ΔRBF), T1 (ΔT1) and T2 (ΔT2) values were assessed at specified time points. Serum levels of cystatin C (CysC) and interleukin-1β (IL-1β), and urinary neutrophil gelatinase-associated lipocalin (NGAL) concentrations were tested as laboratory biomarkers, in addition to examining renal histology and expression levels of various proteins (Rho-kinase [ROCK], α-smooth muscle actin [α-SMA]), hypoxia-inducible factor-1α (HIF-1α), and transforming growth factor-β1 (TGF-β1) that regulate renal fibrosis and hypoxia.Results: Compared with the control group, serum levels of CysC and IL-1β, and urinary NGAL concentrations were clearly increased from Day 1 to Day 13 in the CA-AKI group (all p < 0.05). There were significant reductions in ΔT2 values on Days 1 and 3, and ΔT1 reductions were significantly more pronounced at all time points (Days 1–13) in the CA-AKI + Fasudil group (vs. CA-AKI) (all p < 0.05). Fasudil treatment lowered expression levels of ROCK-1, and p-MYPT1/MYPT1 proteins induced by iopromide, decreasing TGF-β1 expression and suppressing both extracellular matrix accumulation and α-SMA expression relative to untreated status (all p < 0.05). Fasudil also enhanced PHD2 transcription and inhibition of HIF-1α expression after CA-AKI.Conclusions: In the context of CA-AKI, fasudil appears to reduce renal hypoxia, fibrosis, and dysfunction by activating (Rho/ROCK) or inhibiting (TGF-β1, HIF-1α) certain signaling pathways and reducing α-SMA expression. Multiparametric MRI may be a viable noninvasive tool for monitoring CA-AKI pathophysiology during fasudil therapy.https://www.frontiersin.org/articles/10.3389/fphar.2022.905547/fullCA-AKIfasudilmultiparametric MRIRho/ROCKrenal hypoxiarenal fibrosis
spellingShingle Bin Wang
Bin Wang
Yongfang Wang
Yan Tan
Jinxia Guo
Haoyuan Chen
Pu-Yeh Wu
Xiaochun Wang
Hui Zhang
Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
Frontiers in Pharmacology
CA-AKI
fasudil
multiparametric MRI
Rho/ROCK
renal hypoxia
renal fibrosis
title Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
title_full Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
title_fullStr Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
title_full_unstemmed Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
title_short Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
title_sort assessment of fasudil on contrast associated acute kidney injury using multiparametric renal mri
topic CA-AKI
fasudil
multiparametric MRI
Rho/ROCK
renal hypoxia
renal fibrosis
url https://www.frontiersin.org/articles/10.3389/fphar.2022.905547/full
work_keys_str_mv AT binwang assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT binwang assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT yongfangwang assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT yantan assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT jinxiaguo assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT haoyuanchen assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT puyehwu assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT xiaochunwang assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri
AT huizhang assessmentoffasudiloncontrastassociatedacutekidneyinjuryusingmultiparametricrenalmri